Nuo Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NUO THERAPEUTICS, INC. | ||
| Date: March 30, 2026 | By: | /s/ David E. Jorden |
|---|---|---|
| David E. Jorden | ||
| Chief Executive and Financial Officer and Director | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Date: March 30, 2026 | /s/ David E. Jorden |
|---|---|
| David E. Jorden | |
| Chief Executive and Financial Officer and Director | |
| (Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer) | |
| Date: March 30, 2026 | /s/ C. Eric Winzer |
| C. Eric Winzer | |
| Director | |
| Date: March 30, 2026 | /s/ Scott M. Pittman |
| Scott M. Pittman | |
| Director | |
| Date: March 30, 2026 | /s/ Paul D. Mintz |
| Paul D. Mintz | |
| Director |
NUO THERAPEUTICS, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Audited Financial Statements | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB Firm ID No. 206) | F-2 |
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Changes in Stockholders’ Equity (Deficit) | F-5 |
| Consolidated Statements of Cash Flows | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.